Page last updated: 2024-11-06

sodium molybdate(vi)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sodium molybdate(VI): RN given refers to molybdic acid, di-Na salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

sodium molybdate (anhydrous) : An inorganic sodium salt having molybdate as the counterion. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID61424
CHEBI ID75215
MeSH IDM0083179

Synonyms (50)

Synonym
7631-95-0
natriummolybdat
sodium molybdate(vi)
molybdic acid, disodium salt
nsc-77389
disodium molybdate
molybdic acid (h2moo4), disodium salt
molybdate (moo42-), disodium, (t-4)-
nsc 77389
sodium molybdate (van)
natriummolybdat [german]
einecs 231-551-7
molybdic acid (h2moo4) , disodium salt
ccris 5442
molybdate (moo42-), disodium, (beta-4)-
sodium molybdate
chebi:75215 ,
molybdate (moo42-), sodium (1:2), (t-4)-
unii-948qaq08i1
ec 231-551-7
948qaq08i1 ,
molybdate disodium
13466-16-5
sodium dimolybdate
disodium tetraoxomolybdate
sodium molybdate (anh.)
sodium dioxido(dioxo)molybdenum
sodium molybdate (anhydrous)
sodium molybdenum oxide
na2moo4
AKOS015912969
sodium molybdate(vi) [mi]
sodium molybdate [inci]
anhydric sodium molybdate
sodium molybdate [who-dd]
sodium molybdate [vandf]
sodium molybdate [mart.]
molybdenum (as sodium) [vandf]
TVXXNOYZHKPKGW-UHFFFAOYSA-N
sodium molybdate, anhydrous
sodium molybdenum oxide, anhydrous, mo 46.2%
sodium molybdate, anhydrous, powder, -100 mesh particle size, 99.9% trace metals basis
mfcd00003486
sodium molybdate, >=98%
sodium molybdate, lr, >=99.5%
FT-0701280
Q414518
molybdenum (as sodium)
DB14496
disodium;dioxido(dioxo)molybdenum

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Chromium and their compounds are toxic to both invertebrates and vertebrates and, for this reason, there has been a search for suitable and less toxic alternatives."( Toxicity of sodium molybdate and sodium dichromate to Daphnia magna straus evaluated in acute, chronic, and acetylcholinesterase inhibition tests.
Almeida, E; Diamantino, TC; Guilhermino, L; Soares, AM, 2000
)
0.31
" No treatment-related adverse effects on reproductive organ weights or histopathology, estrus cycles or sperm parameters were observed at any dose level."( 90-Day subchronic toxicity study of sodium molybdate dihydrate in rats.
Carey, S; Murray, FJ; Sullivan, FM; Tiwary, AK, 2014
)
0.4
" No adverse effects were observed at any dose level on the dams, or on embryofetal survival, fetal bodyweight, or development, with no increase in malformations or variations."( Developmental toxicity study of sodium molybdate dihydrate administered in the diet to Sprague Dawley rats.
Carey, S; Jay Murray, F; Sullivan, FM; Tiwary, AK; Tyl, RW, 2014
)
0.4
" No adverse effects were observed in birds exposed to MoS2 at the maximum dose of 5000 mg MoS2/kg feed (545 mg MoS2/kg body weight/day)."( Dietary toxicity of soluble and insoluble molybdenum to northern bobwhite quail (Colinus virginianus).
Clark, SL; Engfehr, CL; Fletcher, OJ; Gulde, CM; Lambert, CE; Sample, BE; Stafford, JM; Tiwary, A; Zyskowski, JA, 2016
)
0.43
" No adverse effect on reproductive function was observed at any dose level in either generation as indicated by no significant dose-related effect on estrus cycles, sperm parameters, mating, fertility, gestation, litter size, pup survival, growth or postnatal development."( A two-generation reproductive toxicity study of sodium molybdate dihydrate administered in drinking water or diet to Sprague-Dawley rats.
Carey, S; Hoberman, AM; Hubbard, SA; Murray, FJ; Sullivan, FM, 2019
)
0.51
" Water consumption was increased compared to controls at both dose levels during the pre-mating and gestation periods, with no apparent adverse impact."( Sodium molybdate dihydrate does not exhibit developmental or reproductive toxicity in Sprague-Dawley rats maintained on a marginal copper diet.
Aveyard, L; Carey, S; Hoberman, AM; Hubbard, SA; Murray, FJ, 2023
)
0.91

Bioavailability

ExcerptReferenceRelevance
" The chemical form and bioavailability of Mo is important in determining its toxicity."( Dietary toxicity of soluble and insoluble molybdenum to northern bobwhite quail (Colinus virginianus).
Clark, SL; Engfehr, CL; Fletcher, OJ; Gulde, CM; Lambert, CE; Sample, BE; Stafford, JM; Tiwary, A; Zyskowski, JA, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" A dose-response in both kinetochore-positive MN (caused by chromosome lagging) and kinetochore-negative MN (associated with chromosome breakage) was observed."( Studies on the genotoxicity of molybdenum salts in human cells in vitro and in mice in vivo.
Ngo, H; Shang, N; Shao, J; Smith, MT; Titenko-Holland, N; Xi, L; Zhang, L, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
poisonAny substance that causes disturbance to organisms by chemical reaction or other activity on the molecular scale, when a sufficient quantity is absorbed by the organism.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
inorganic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
16p11.2 proximal deletion syndrome039

Research

Studies (253)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990156 (61.66)18.7374
1990's31 (12.25)18.2507
2000's20 (7.91)29.6817
2010's33 (13.04)24.3611
2020's13 (5.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.12 (24.57)
Research Supply Index5.58 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.76%)5.53%
Reviews2 (0.76%)6.00%
Case Studies1 (0.38%)4.05%
Observational0 (0.00%)0.25%
Other258 (98.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]